Amarantus Bioscience appoints Dr David Lowe to its Board as Independent Director
– USA, CA – Amarantus Bioscience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to neurodegeneration and apoptosis, today announced the appointment of David A.…